ZNRF3 and neoplasm: We previously showed that conditional ablation of Znrf3 within steroidogenic cells of the adrenal cortex resulted in moderate WNT pathway activation and adrenal zona fasciculata hyperplasia up to 6 weeks, suggesting that ZNRF3 was a potential tumor suppressor in the adrenal cortex (30).